TGFBR1 and neoplasm: As mentioned above, our own observations indicate that PAR2 expression is required for full-blown TGF-β/ALK5-induced migratory responses in vitro. Preclinical studies have provided convincing evidence that targeting the TGF-β pathway is able to inhibit tumor growth and metastasis in vivo[256].